sur Zomedica Corp. (NASDAQ:ZOM)
Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota
Zomedica Corp. (NYSE American:ZOM), a veterinary health company, has completed renovations at its 30,000-square-foot facility in Plymouth, Minnesota. The upgrades feature an expanded cleanroom, a new automated production line for TRUFORMA® consumable cartridges, and enhanced distribution facilities.
The company states that the new automated production line can produce up to one million cartridges annually. This improvement is expected to increase manufacturing capacity and shipping efficiency, meeting the growing demand for TRUFORMA cartridges.
CEO Larry Heaton highlighted the importance of these renovations in sustaining Zomedica's growth and capability to develop their assay portfolio. COO Tony Blair added that the new line is operational, marking a significant boost in manufacturing capacity and efficiency.
The TRUFORMA diagnostic platform employs Qorvo Inc.'s Bulk Acoustic Wave (BAW) sensor technology, offering precise diagnostic measurements that aid veterinarians in diagnosing complex conditions in animals. It provides reference-lab quality results at the point of care.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Zomedica Corp.